Cornerstone Advisors LLC Has $95,000 Stock Holdings in Corteva, Inc. $CTVA

Cornerstone Advisors LLC reduced its holdings in Corteva, Inc. (NYSE:CTVA) by 90.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,400 shares of the company’s stock after selling 13,900 shares during the period. Cornerstone Advisors LLC’s holdings in Corteva were worth $95,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. raised its stake in Corteva by 0.5% during the 2nd quarter. Vanguard Group Inc. now owns 80,188,326 shares of the company’s stock valued at $5,976,436,000 after purchasing an additional 373,680 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Corteva by 1.4% during the second quarter. Geode Capital Management LLC now owns 18,047,263 shares of the company’s stock valued at $1,339,651,000 after buying an additional 251,693 shares during the last quarter. Franklin Resources Inc. raised its position in shares of Corteva by 4.9% during the second quarter. Franklin Resources Inc. now owns 17,680,238 shares of the company’s stock valued at $1,317,708,000 after buying an additional 824,451 shares during the last quarter. Norges Bank bought a new stake in shares of Corteva in the second quarter valued at about $434,220,000. Finally, Bank of New York Mellon Corp grew its position in Corteva by 2.7% during the second quarter. Bank of New York Mellon Corp now owns 5,256,845 shares of the company’s stock worth $391,793,000 after buying an additional 138,484 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Performance

NYSE:CTVA opened at $77.00 on Friday. The stock has a market capitalization of $51.78 billion, a P/E ratio of 48.74, a price-to-earnings-growth ratio of 2.61 and a beta of 0.75. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $77.41. The firm has a 50 day moving average of $70.51 and a 200-day moving average of $68.57.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. The firm had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business’s revenue was down 1.7% on a year-over-year basis. During the same period last year, the firm posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be paid a $0.18 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is currently 45.57%.

Wall Street Analysts Forecast Growth

CTVA has been the topic of a number of research reports. Argus upgraded Corteva to a “strong-buy” rating in a research report on Friday, January 16th. Wall Street Zen downgraded shares of Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Wells Fargo & Company lifted their price objective on Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. UBS Group lowered Corteva from a “buy” rating to a “hold” rating in a research note on Monday, February 9th. Finally, CICC Research raised their target price on Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 11th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, Corteva has an average rating of “Moderate Buy” and a consensus target price of $82.30.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.